- LATIN AMERICA
- MIDDLE EAST
- United Kingdom
- United States
- New Zealand
- South Africa
Johnson & Johnson Common Stock (JNJ)
Johnson & Johnson Corporation is a publicly traded company listed on the New York Stock Exchange under the ticker symbol "JNJ" and is a component of the Dow 30 and S&P 500 Index.
Johnson & Johnson (JNJ) operates in the healthcare sector, specifically in the pharmaceuticals, medical devices, and consumer health products industries.
Johnson & Johnson (JNJ) is classified under the Health Care sector of the Global Industry Classification Standard (GICS). Within the Health Care sector, JNJ is further classified under the Pharmaceuticals, Biotechnology & Life Sciences Industry Group. This industry group includes companies involved in the development, production, and marketing of drugs, biotechnology products, and other life sciences-related products and services.
Johnson & Johnson Common Stock Dividend
Johnson & Johnson has been paying a quarterly dividend to its shareholders of $1.13 per share since June, 2022. Johnson & Johnson has increased its dividend payout consistently over the past decade.
The dividend payout history and dividend growth are important factors for investors to consider when evaluating a stock's potential for income. Johnson & Johnson has a history of paying dividends, and the company has been increasing its dividend payout in recent years.
However, it's important to note that dividend payments are not guaranteed, and can be affected by a range of factors, including the company's financial performance, changes in the regulatory environment, and other economic factors.
JNJ price today by TradingView
About Johnson & Johnson (JNJ)
Johnson & Johnson is a multinational corporation that produces a wide range of healthcare products, including pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is headquartered in New Brunswick, NJ.
Johnson & Johnson is one of the largest healthcare companies in the world, with operations in over 60 countries and a workforce of approximately 152,000 employees. The company's portfolio includes well-known brands such as Tylenol, Band-Aid, Neutrogena, and Listerine, as well as prescription medications for a variety of conditions.
In recent years, Johnson & Johnson has faced some high-profile legal challenges related to certain products, including lawsuits over its talcum powder and pelvic mesh products. The company has also been involved in the development and distribution of COVID-19 vaccines, producing a single-dose vaccine that has been authorized for emergency use in multiple countries.
Johnson & Johnson produces a wide range of healthcare products, including:
Johnson & Johnson's pharmaceutical division, Janssen Pharmaceuticals, produces prescription medications for a variety of conditions, including cancer, HIV, and mental health disorders.
Johnson & Johnson's medical device division produces products such as surgical instruments, orthopedic implants, and contact lenses.
Consumer health products
Johnson & Johnson's consumer health division produces over-the-counter medications, first aid products, baby products, and personal care products, including:
Tylenol and Motrin pain relievers
Neutrogena skincare products
Aveeno skincare products
Benadryl allergy medication
Johnson's baby products
Rogaine hair loss treatment
Acuvue contact lenses
Johnson & Johnson also produces vaccines for a variety of diseases, including the COVID-19 vaccine that has been authorized for emergency use in multiple countries.
ohnson & Johnson (JNJ) History
Johnson & Johnson (JNJ) was founded in 1886 by three brothers: Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson.
The company began as a manufacturer of sterile surgical dressings, and quickly expanded into other medical products such as sutures and bandages.
Throughout its history, JNJ has been known for its innovation in healthcare products and technologies. In 1921, the company introduced the first commercial first aid kits for use in homes and automobiles. In 1944, JNJ developed the first mass-produced sterile surgical sutures, which revolutionized surgical procedures. In 1961, JNJ introduced Tylenol, one of the most popular over-the-counter pain relief medications in the world.
In addition to its innovation, JNJ has also been recognized for its commitment to social responsibility and corporate citizenship. In 1982, JNJ established the Johnson & Johnson Family of Companies Foundation, which supports programs and initiatives that promote access to health care and education around the world. JNJ has also been recognized for its sustainability efforts, including its commitment to reducing its carbon footprint and increasing its use of renewable energy sources.
JNJ fundamentals by TradingView